Published in Am J Gastroenterol on September 01, 1998
Apoptosis, proliferation and p53 gene expression of H. pylori associated gastric epithelial lesions. World J Gastroenterol (2001) 1.22
Effect of preoperative regional artery chemotherapy on proliferation and apoptosis of gastric carcinoma cells. World J Gastroenterol (2002) 1.00
Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998. Dig Dis Sci (2001) 0.93
Cytotoxic T cells in H. pylori-related gastric autoimmunity and gastric lymphoma. J Biomed Biotechnol (2010) 0.90
Helicobacter pylori eradication for gastric cancer prevention. J Gastroenterol (2007) 0.89
Gastric emptying and dyspeptic symptoms in patients with nonautoimmune fundic atrophic gastritis. Dig Dis Sci (2000) 0.87
Reversal of gastric atrophy after Helicobacter pylori eradication: is it possible or not? Am J Gastroenterol (1998) 0.80
Sustained epithelial proliferation in a functionally irreversible fundic mucosa after Helicobacter pylori eradication. J Gastroenterol (2009) 0.80
Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysis. World J Gastroenterol (2014) 0.79
Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis. J Gastroenterol (2009) 0.79
Gastric emptying in diabetic patients by the (13)C-octanoic acid breath test: role of insulin in gastric motility. J Gastroenterol (2007) 0.79
Indications for Helicobacter pylori eradication therapy and first-line therapy regimen in Japan: recommendation by the Japanese Society for Helicobacter Research. J Gastroenterol (2002) 0.78
Follow-Up Study on CDX1 and CDX2 mRNA Expression in Noncancerous Gastric Mucosae After Helicobacter pylori Eradication. Dig Dis Sci (2016) 0.76
Gastric mucosa: long-term outcome after cure of Helicobacter pylori infection. J Gastroenterol (2002) 0.76
Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection. Wien Klin Wochenschr (2004) 0.76
Helicobacter pylori infection and gastric function in patients with fundic atrophic gastritis. Dig Dis Sci (2001) 0.76
A patient with impaired gastric motility. Gut (2007) 0.75
Serum-free culture of H pylori intensifies cytotoxicity. World J Gastroenterol (2007) 0.75
Expression of CDX2 in gastriccardia adenocarcinoma and its correlation with H. pylori and cell proliferation. Oncotarget (2016) 0.75
Supra-angular biopsy is more reliable for atrophy recognization: analysis of 1598 cases for gastric mucosal histological examination. World J Gastroenterol (2000) 0.75
Functional gastroduodenal disorders. Gut (1999) 3.74
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut (2008) 3.52
HCV-associated liver cancer without cirrhosis. Lancet (1995) 3.23
Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology (1996) 3.22
Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol (2000) 3.08
The SLT2(MPK1) MAP kinase is activated during periods of polarized cell growth in yeast. EMBO J (1996) 2.74
Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut (1987) 2.46
Manometric evaluation of functional upper gut symptoms. Gastroenterology (1985) 2.38
Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med (1990) 2.36
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28
Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease. N Engl J Med (1988) 2.27
One-day therapy for treatment of Helicobacter pylori infection. Dig Dis Sci (1993) 2.27
Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci (1989) 2.23
Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome. Am J Gastroenterol (2013) 2.21
Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut (2004) 2.04
Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil (2011) 1.99
What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol (1997) 1.98
Real-time detection of Helicobacter Pylori infection and atrophic gastritis: comparison between conventional methods and a novel device for gastric juice analysis during endoscopy. Endoscopy (2005) 1.97
Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am J Trop Med Hyg (1993) 1.90
Gastro-oesophageal reflux and interstitial lung disease. Dig Liver Dis (2006) 1.85
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Aliment Pharmacol Ther (2009) 1.83
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther (2012) 1.79
Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther (1999) 1.76
Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res (2004) 1.76
Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology (1992) 1.72
The general practitioner's approach to irritable bowel syndrome: from intention to practice. Dig Liver Dis (2005) 1.62
Correlation between detection of plasminogen cross-reactive antibodies and hemorrhage in dengue virus infection. J Infect Dis (1994) 1.60
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. Gut (2008) 1.59
Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest. Digestion (2004) 1.57
A role for inflammation in irritable bowel syndrome? Gut (2002) 1.57
Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? The Italian Helicobacter pylori Study Group. Endoscopy (1997) 1.52
New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther (2004) 1.45
Stress-induced gastroduodenal motor disturbances in humans: possible humoral mechanisms. Gastroenterology (1983) 1.40
Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology (1992) 1.40
Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection. Ital J Gastroenterol (1994) 1.38
Fasting and postprandial gastrointestinal motility in ulcer and non-ulcer dyspepsia. Gut (1992) 1.38
Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. Am J Pathol (1996) 1.37
Familial syndrome of midsystolic click and late systolic murmur. Br Heart J (1973) 1.32
New insights into human enteric neuropathies. Neurogastroenterol Motil (2004) 1.31
Review article: the pharmacological treatment of acute colonic pseudo-obstruction. Aliment Pharmacol Ther (2001) 1.24
Review article: molecular, pathological and therapeutic features of human enteric neuropathies. Aliment Pharmacol Ther (2008) 1.24
Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil (2006) 1.23
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut (1994) 1.22
Apoptotic cell death of human interstitial cells of Cajal. Neurogastroenterol Motil (2008) 1.20
Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer. Lancet (1989) 1.19
Gastrointestinal motility disturbances in patients with orthostatic hypotension. Gastroenterology (1985) 1.16
Relapsing ulcerative colitis after spinal cord stimulation: a case of intestinal neurogenic inflammation? Gastroenterology (1999) 1.16
Clinical experience with hepatic resections for hepatocellular carcinoma in patients with cirrhosis. Surg Gynecol Obstet (1988) 1.16
Can antigliadin antibody detect symptomless coeliac disease in children with short stature? Lancet (1985) 1.14
Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology (1993) 1.13
Hypersensitivity reactions related to oxaliplatin (OHP). Br J Cancer (2003) 1.11
Gastric secretion and emptying of liquids in reflex esophagitis. Dig Dis Sci (1981) 1.11
Carotid plaque, aging, and risk factors. A study of 457 subjects. Stroke (1994) 1.10
Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia. Gut (1997) 1.09
Esophageal and gastric nitric oxide synthesizing innervation in primary achalasia. Am J Gastroenterol (1999) 1.09
Effect of opiate and adrenergic blockers on the gut motor response to centrally acting stimuli. Gastroenterology (1984) 1.08
Predominant symptoms identify different subgroups in functional dyspepsia. Am J Gastroenterol (1999) 1.07
Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial. J Am Coll Cardiol (1995) 1.06
Novel clinically relevant genes in GIST--letter. Clin Cancer Res (2014) 1.05
The influence of endoscopic biliary stents on the accuracy of endoscopic ultrasound for pancreatic head cancer staging. Endoscopy (2007) 1.04
Morphologic and cytoproliferative patterns of duodenal mucosa in two patients after long-term total parenteral nutrition: changes with oral refeeding and relation to intestinal resection. JPEN J Parenter Enteral Nutr (1994) 1.03
Role of nitric oxide- and vasoactive intestinal polypeptide-containing neurones in human gastric fundus strip relaxations. Br J Pharmacol (2000) 1.02
Primary enteric neuropathies underlying gastrointestinal motor dysfunction. Scand J Gastroenterol (2000) 1.01
Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy. Dig Dis Sci (1996) 0.99
Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study. Aliment Pharmacol Ther (1998) 0.99
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice. Br J Cancer (2008) 0.98
Apoptosis and aging in mitochondrial morphology mutants of S. cerevisiae. Folia Microbiol (Praha) (2007) 0.98
Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology (1996) 0.97
Rectal cell proliferation and colorectal cancer risk level in patients with nonfamilial adenomatous polyps of the large bowel. Cancer (1991) 0.97
Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult. Eur J Gastroenterol Hepatol (2000) 0.97
Pseudo-obstruction syndromes. Baillieres Clin Gastroenterol (1988) 0.96
Arcobacter cryaerophilus and thermophilic campylobacters in a sewage treatment plant in Italy: two secondary treatments compared. Epidemiol Infect (1993) 0.96
Synchronous and metachronous cancer of the stomach. Eur J Surg Oncol (1987) 0.95
Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD. Digestion (2004) 0.95
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer. Ann Oncol (2008) 0.95
Combined liver-kidney transplantation in polycystic disease: case reports. Transplant Proc (2008) 0.95
Gastric manometric abnormalities in patients with dyspeptic symptoms after fundoplication. Gut (1983) 0.94
Gastric emptying of solids in morbid obesity. Int J Obes Relat Metab Disord (1996) 0.94
Intraoperative ultrasonography in surgery for liver tumors. Surgery (1986) 0.93
Short stature and celiac disease: a relationship to consider even in patients with no gastrointestinal tract symptoms. J Pediatr (1983) 0.93
Dynamic intracavitary left atrial echoes in mitral stenosis. Am J Cardiol (1985) 0.93
Cell proliferation of the duodenal mucosa in patients affected by familial adenomatous polyposis. Gastroenterology (1997) 0.93
Ultrasonic endoscopy--the gastrointestinal wall. Scand J Gastroenterol Suppl (1984) 0.92
Management of Helicobacter pylori-related gastrointestinal diseases by general practitioners in Italy. Aliment Pharmacol Ther (1999) 0.91
Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors. Transplant Proc (2010) 0.91
Familial association of benign pancreatic hyperenzymaemia and pancreatic cancer. Gut (2007) 0.91
Effect of ranitidine and cimetidine on gastric emptying of a mixed meal in man. Int J Clin Pharmacol Ther Toxicol (1984) 0.91
Search for human papillomavirus, herpes simplex virus and c-myc oncogene in human genital tumors. Int J Cancer (1989) 0.91